The Kevzara market is witnessing steady growth over the forecast period, supported by increasing autoimmune disease burden, expansion into additional inflammatory indications.
Read More
The Kesimpta market is witnessing steady growth over the forecast period, supported by growing relapsing ms population, increased home injection adoption.
Read More
The Kepivance market is witnessing steady growth over the forecast period, supported by rising cancer treatment volumes, growth in hematopoietic stem cell transplants.
Read More
The Kedrab market is witnessing steady growth over the forecast period, supported by increasing animal bite incidents, expansion of rabies awareness campaigns.
Read More
The Kedbumin market is witnessing steady growth over the forecast period, supported by rising intensive care admissions, growth in liver disease prevalence.
Read More
The Kcentra market is witnessing steady growth over the forecast period, supported by aging population on anticoagulants, rising emergency surgical procedures.
Read More
The Kanuma market is witnessing steady growth over the forecast period, supported by expansion of newborn screening programs, advancements in recombinant enzyme technology.
Read More
The Kalbitor market is witnessing steady growth over the forecast period, supported by increasing genetic diagnosis of hae, growth in targeted biologic therapies.
Read More
The Kadcyla market is witnessing steady growth over the forecast period, supported by rising incidence of her2 positive breast cancer, expansion of adc pipelines.
Read More
The Jynneos market is witnessing steady growth over the forecast period, supported by increasing zoonotic disease risks, expansion of national vaccine reserves.
Read More